These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10893956)
1. [Safety in routine clinical practice. Hypersensitivity can be managed]. MMW Fortschr Med; 2000; 142(3 Suppl):22-3. PubMed ID: 10893956 [No Abstract] [Full Text] [Related]
2. Large lymphadenopathies complicating the abacavir hypersensitivity reaction. García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059 [No Abstract] [Full Text] [Related]
3. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients. Bellagamba R; Tommasi C; De Marco M; Narciso P J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915 [No Abstract] [Full Text] [Related]
4. Response to: Are all non-thymidine analogue backbones appropriate for treating antiretroviral-naïve patients? Brothers C; Cutrell A; Scott T; Hernandez J; Moult A Int J Clin Pract; 2006 May; 60(5):611-2; author reply 612. PubMed ID: 16700867 [No Abstract] [Full Text] [Related]
5. [Highly active antiretroviral therapy. A simple combination, but high effectiveness]. MMW Fortschr Med; 2000; 142(3 Suppl):20-2. PubMed ID: 10893955 [No Abstract] [Full Text] [Related]
6. Warning against rechallenge with abacavir. AIDS Patient Care STDS; 1998 Mar; 12(3):229. PubMed ID: 11361938 [No Abstract] [Full Text] [Related]
11. Hypersensitivity reactions due to abacavir. Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446 [TBL] [Abstract][Full Text] [Related]
12. Unusual clinical presentation of hypersensitivity reaction to abacavir. Aquilina C; Mularczyk M; Lucas F; Viraben R AIDS; 2003 Nov; 17(16):2403-4. PubMed ID: 14571198 [No Abstract] [Full Text] [Related]
13. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction. AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210 [TBL] [Abstract][Full Text] [Related]
14. Development of abacavir hypersensitivity reaction after rechallenge in a previously asymptomatic patient. El-Sahly HM AIDS; 2004 Jan; 18(2):359-60. PubMed ID: 15075569 [No Abstract] [Full Text] [Related]
15. Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate. Fontaine C; Guiard-Schmid JB; Slama L; Essid A; Lukiana T; Rondeau E; Pialoux G AIDS; 2005 Nov; 19(16):1927-8. PubMed ID: 16227807 [No Abstract] [Full Text] [Related]
16. [Delayed drug sensitivity]. del Valle Loarte P; Cervero Jiménez M; Joya Seijo MD; Jusdado Ruiz-Capillas JJ; Torres Perea R Rev Clin Esp; 2003 Dec; 203(12):617-8. PubMed ID: 14622520 [No Abstract] [Full Text] [Related]
17. Agranulocytosis and fever seven weeks after starting abacavir. Sankatsing SU; Prins JM AIDS; 2001 Dec; 15(18):2464-5. PubMed ID: 11774836 [No Abstract] [Full Text] [Related]
18. Abacavir hypersensitivity reaction. AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699 [No Abstract] [Full Text] [Related]
19. Next HIV guidelines likely to include salvage therapy. AIDS Alert; 1999 Jul; 14(7):76-8. PubMed ID: 11366417 [TBL] [Abstract][Full Text] [Related]